Octavio Espinoza

Insider Reports History

Location
San Diego, CA
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Octavio Espinoza
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Octavio Espinoza:

Company Role Class Num Shares Value Price $ Report Date Ownership
LIGAND PHARMACEUTICALS INC Chief Financial Officer Common Stock 28,575 $2,733,941 $95.68 31 Dec 2025 Direct
LIGAND PHARMACEUTICALS INC Chief Financial Officer Employee Stock Option (right to buy) 4,186 16 Dec 2025 Direct

Insider Reports Filed by Octavio Espinoza

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LGND LIGAND PHARMACEUTICALS INC 31 Dec 2025 1 +$765 4 Chief Financial Officer 06 Jan 2026, 19:21
LGND LIGAND PHARMACEUTICALS INC 16 Dec 2025 10 +$164,298 4 Chief Financial Officer 18 Dec 2025, 16:19
LGND LIGAND PHARMACEUTICALS INC 12 Dec 2025 1 -$339,711 4 Chief Financial Officer 16 Dec 2025, 18:36
LGND LIGAND PHARMACEUTICALS INC 05 Dec 2025 1 -$344,228 4 Chief Financial Officer 09 Dec 2025, 20:06
LGND LIGAND PHARMACEUTICALS INC 30 Jun 2025 1 +$20,401 4 Chief Financial Officer 02 Jul 2025, 19:32
LGND LIGAND PHARMACEUTICALS INC 09 May 2025 2 +$156,090 4 Chief Financial Officer 13 May 2025, 20:04
LGND LIGAND PHARMACEUTICALS INC 04 Mar 2025 3 -$575,148 4 Chief Financial Officer 06 Mar 2025, 18:55
LGND LIGAND PHARMACEUTICALS INC 14 Feb 2025 7 -$1,150,440 4 Chief Financial Officer 19 Feb 2025, 20:38
LGND LIGAND PHARMACEUTICALS INC 23 Dec 2024 1 -$244,850 4 Chief Financial Officer 26 Dec 2024, 20:32
LGND LIGAND PHARMACEUTICALS INC 05 Dec 2024 1 -$229,605 4 Chief Financial Officer 06 Dec 2024, 19:55
LGND LIGAND PHARMACEUTICALS INC 20 Sep 2024 3 -$132,518 4 Chief Financial Officer 24 Sep 2024, 19:41
LGND LIGAND PHARMACEUTICALS INC 17 Sep 2024 4 +$118,328 4 Chief Financial Officer 19 Sep 2024, 17:50
LGND LIGAND PHARMACEUTICALS INC 28 Aug 2024 4 +$50,086 4 Chief Financial Officer 30 Aug 2024, 21:00
LGND LIGAND PHARMACEUTICALS INC 28 Jun 2024 1 +$16,209 4 Chief Financial Officer 02 Jul 2024, 19:45
LGND LIGAND PHARMACEUTICALS INC 15 May 2024 12 -$761,357 4 Chief Financial Officer 17 May 2024, 19:59
LGND LIGAND PHARMACEUTICALS INC 27 Feb 2024 9 +$59,180 4 Chief Financial Officer 29 Feb 2024, 18:50
LGND LIGAND PHARMACEUTICALS INC 15 Feb 2024 1 -$110,407 4 Chief Financial Officer 16 Feb 2024, 20:10
LGND LIGAND PHARMACEUTICALS INC 05 Dec 2023 1 -$75,645 4 Chief Financial Officer 06 Dec 2023, 15:27
LGND LIGAND PHARMACEUTICALS INC 01 Oct 2023 1 -$20,732 4 Chief Financial Officer 03 Oct 2023, 16:36
LGND LIGAND PHARMACEUTICALS INC 30 Jun 2023 1 +$21,292 4 Chief Financial Officer 10 Jul 2023, 18:42
LGND LIGAND PHARMACEUTICALS INC 23 Feb 2023 2 $0 4 Chief Financial Officer 27 Feb 2023, 19:54
LGND LIGAND PHARMACEUTICALS INC 15 Feb 2023 1 -$61,960 4 Chief Financial Officer 17 Feb 2023, 18:20
LGND LIGAND PHARMACEUTICALS INC 30 Dec 2022 1 +$15,614 4 Chief Financial Officer 04 Jan 2023, 16:00
LGND LIGAND PHARMACEUTICALS INC 22 Dec 2022 1 $0 4 Chief Financial Officer 27 Dec 2022, 17:26
LGND LIGAND PHARMACEUTICALS INC 13 Dec 2022 2 $0 4 Chief Financial Officer 15 Dec 2022, 17:13
LGND LIGAND PHARMACEUTICALS INC 30 Nov 2022 1 -$86,532 4 Chief Financial Officer 01 Dec 2022, 20:41
LGND LIGAND PHARMACEUTICALS INC 09 Nov 2022 1 -$128,283 4 Chief Financial Officer 10 Nov 2022, 15:30
LGND LIGAND PHARMACEUTICALS INC 01 Nov 2022 0 $0 3/A Chief Financial Officer 02 Jul 2025, 19:03
LGND LIGAND PHARMACEUTICALS INC 01 Nov 2022 0 $0 3 Chief Financial Officer 07 Nov 2022, 19:26